Open Access

Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis

  • Authors:
    • Jian Zhang
    • Chunying Wang
    • Ji Wang
    • Fengchi Zhang
  • View Affiliations

  • Published online on: November 10, 2017     https://doi.org/10.3892/etm.2017.5490
  • Pages: 723-726
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

This study was conducted to analyze the change in intestinal flora of patients with nonalcoholic steatohepatitis and its correlation to the levels of the inflammatory cytokines interleukin-10 (IL-10) and IL-17. We selected 90 patients that were diagnosed with and treated for nonalcoholic steatohepatitis as the patient group and 80 healthy cases as the control group. We then compared the intestinal flora in the subject feces and the intestinal colonization resistance (B/E, Bifidobacterium to Enterobacter) of both groups. Using RT-PCR, we also detected IL-10 and IL-17 mRNA levels in the peripheral blood mononuclear cells of both groups. Furthermore, we used the ELISA method to determine serum IL-10 and IL-17 levels in order to explore the correlation between IL-10, IL-17 and B/E. The number of Bifidobacterium and Lactobacillus were significantly lower in the patient group than the control group (P<0.05), while Enterobacter and Enterococcus pathogenic bacteria were significantly higher in the patient group than the control group (P<0.05). The B/E value was lower in the patient group than the control group (P<0.05). The relative expression of IL-10 and IL-17 mRNA in the patient group was significantly higher than in the control group (P<0.05). In the patient group, the serum IL-10 levels were 1.17±0.15 pg/ml, which is significantly higher than the control group serum IL-10 levels which were 0.32±0.04 pg/ml (P<0.05). The serum IL-17 levels in the patient groups were 0.96±0.11 pg/ml, which was significantly higher than the control group, which had an average of 0.28±0.01 pg/ml serum IL-17 levels (P<0.05). Pearson's correlation analysis showed that the change of B/E value of intestinal flora in the patients group were negatively correlated with serum IL-10 (r=-0.546, P<0.05), and negatively correlated with serum IL-17 (r=-0.535, P<0.05). Therefore, compared to healthy people, the expression of IL-10 and IL-17 in the peripheral blood of patients with non-alcoholic fatty liver is high. The changes in intestinal flora in patients with nonalcoholic steatohepatitis are closely related to the changes of serum IL-10 and IL-17 levels, and they are involved in the development of nonalcoholic steatohepatitis.

References

1 

Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD and Gill SR: Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH. Hepatology. 57:601–609. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Ilan Y: Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol. 18:2609–2618. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Wu WC, Zhao W and Li S: Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. World J Gastroenterol. 14:313–317. 2008. View Article : Google Scholar : PubMed/NCBI

4 

Tsujimoto T, Kawaratani H, Kitazawa T, Uemura M and Fukui H: Innate immune reactivity of the ileum-liver axis in nonalcoholic steatohepatitis. Dig Dis Sci. 57:1144–1151. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Safadi R, Konikoff FM, Mahamid M, Zelber-Sagi S, Halpern M, Gilat T, Oren R, Safadi R, Konikoff FM, Hershkovitz A, et al FLORA Group, : The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 12:2085–91.e1. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Santos LF, Hernández G, Puerta AV, Beltrán O, Botero RC and Mejía G: Non alcoholic fatty liver disease: The new millennium pandemia. Rev Col Gastroenterol. 25:380–398. 2010.

7 

Schartum-Hansen H, Pedersen ER, Svingen GF, Ueland PM, Seifert R, Ebbing M, Strand E, Bleie Ø and Nygård O: Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. Eur J Prev Cardiol. 22:606–614. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P and Ekesbo R: Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial. Scand J Gastroenterol. 46:663–672. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, et al: Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 57:1488–1495. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H and Verhaegen J: Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy - should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect. 18:575–581. 2012.PubMed/NCBI

11 

Hotten P, Marotta F, Naito Y, Minelli E, Helmy A, Lighthouse J, Fuji H and Fesce E: Effects of probiotics, lactitol and rifaximin on intestinal flora and fecal excretion of organic acids in cirrhotic patients. Chin J Dig Dis. 4:13–18. 2003. View Article : Google Scholar

12 

Xu RY, Wan YP, Fang QY, Lu W and Cai W: Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. J Clin Biochem Nutr. 50:72–77. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Omura Y, Kitamoto M, Hyogo H, Yamanoue T, Tada Y, Boku N, Nishisaka T, Miyauchi M, Takata T and Chayama K: Morbidly obese patient with non-alcoholic steatohepatitis-related cirrhosis who died from sepsis caused by dental infection of Porphyromonas gingivalis: A case report. Hepatol Res. 46:E210–E215. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Habior A: Nonalcoholic fatty liver disease and obesity. Nutr Clin Pract. 22:1–10. 2013.(In Polish).

15 

El-Bassiouni NE, El Messery LO, Zayed RA, Metwally OB, Zahran MY, Mahmoud OM, Ibrahim RA and El Bassiouny AE: Tissue factor expression on blood monocytes in patients with hepatitis C virus-induced chronic liver disease. Comp Clin Pathol. 23:1159–1166. 2014. View Article : Google Scholar

16 

Tarantino G: Nutrition: A promising route for prevention and management of obesity-related nonalcoholic fatty liver disease. Horm Mol Biol Clin Investig. 20:39–41. 2014.PubMed/NCBI

17 

Mcavoy NC, Ferguson JW, Campbell IW and Hayes PC: Review: Non-alcoholic fatty liver disease: natural history, pathogenesis and treatment. Br J Diabetes Vasc Dis. 6:251–260. 2006. View Article : Google Scholar

18 

Kwak DS, Jun DW, Seo JG, Chung WS, Park SE, Lee KN, Khalid-Saeed W, Lee HL, Lee OY, Yoon BC, et al: Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease. Eur J Gastroenterol Hepatol. 26:1353–1359. 2014.PubMed/NCBI

Related Articles

Journal Cover

January 2018
Volume 15 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhang, J., Wang, C., Wang, J., & Zhang, F. (2018). Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis. Experimental and Therapeutic Medicine, 15, 723-726. https://doi.org/10.3892/etm.2017.5490
MLA
Zhang, J., Wang, C., Wang, J., Zhang, F."Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis". Experimental and Therapeutic Medicine 15.1 (2018): 723-726.
Chicago
Zhang, J., Wang, C., Wang, J., Zhang, F."Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis". Experimental and Therapeutic Medicine 15, no. 1 (2018): 723-726. https://doi.org/10.3892/etm.2017.5490